Avanos Medical, Inc. (NYSE:AVNS) Q4 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to Avanos Fourth Quarter 2025 Earnings Conference Call.
Avanos Medical Inc. (AVNS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Diamond Hill Capital Ric Dillon | 573,940 | $8,040,899 | +13% | 0.05% |
| 2. | Levin Easterly Partners John Murphy | 0 | $0 | 0% | |
| 3. | Walleye Capital Will England | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.00 | 40,000 | $439,800.00 | 40,000 | 2025-08-13 | Filing | |
| $10.98 | 20,000 | $219,500.00 | 91,593 | 2025-08-13 | Filing | |
| $19.85 | 500 | $9,925.00 | 50,090 | 2024-03-11 | Filing | |
| $31.67 | 800 | $25,336.00 | 33,900 | 2021-09-15 | Filing | |
| $31.65 | 900 | $28,485.00 | 33,100 | 2021-09-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.02 | 305 | $3,361.10 | 83,860 | 2025-11-18 | Filing | |
| $11.01 | 761 | $8,378.61 | 84,165 | 2025-11-18 | Filing | |
| $11.01 | 100 | $1,100.50 | 84,926 | 2025-11-18 | Filing | |
| $11.00 | 13,834 | $152,174.00 | 85,026 | 2025-11-18 | Filing | |
| $15.25 | 7,000 | $106,778.00 | 82,047 | 2025-03-06 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,052,356 | $28,752,636 | 0.01% | |
| 2. | 1,971,965 | $27,627,230 | 0% | |
| 3. | 1,239,295 | $17,362,523 | 0% | |
| 4. | 845,000 | $11,838,450 | 2.84% | |
| 5. | 304,726 | $4,269,214 | 0% |
News See All
Avanos Medical, Inc. (AVNS): A Bull Case Theory
We came across a bullish thesis on Avanos Medical, Inc. on Ridire Research’s Substack. In this article, we will summarize the bulls’ thesis on AVNS.
Avanos Medical, Inc. (NYSE:AVNS) Q3 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Avanos Third Quarter 2025 Earnings Conference Call. [Operator Instructions] This call is being recorded on Wednesday, November 5, 2025.
Avanos Medical, Inc. (NYSE:AVNS) Q2 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Avanos Second Quarter 2025 Earnings Conference Call.
10 Undervalued Medical Device Stocks to Buy Now
According to a report by Mordor Intelligence, the medical device industry is valued at $681.57 billion as of 2025.
Avanos Medical, Inc. (NYSE:AVNS) Q1 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Avanos Medical, Avanos First Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Tuesday, May 6, 2025.
Avanos Medical (AVNS): Positioned for Growth Under New Leadership
Diamond Hill Capital, an investment management company, released its “Small Cap Fund” first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Avanos Medical, Inc. (NYSE:AVNS) Q4 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Welcome to the Avanos Medical, Inc. fourth quarter 2024 earnings call. At this time, all lines are in listen-only mode.
Avanos (AVNS) Declined due to Reduced Earnings Guidance
Rewey Asset Management, an investment management company, released its “RAM Smid Composite” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Avanos Medical, Inc. (NYSE:AVNS) Q3 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Avanos Medical, Avanos Third Quarter 2024 Earnings Call.
Hedge Fund Resource Center